
Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Is It a R N A, I Mr an M R N A?
R n a is getting all sorts of attention right now. The stuff that we're putting out on this is, like, it's crushing our engagement metric records. I think you'll also see utility in ocology, for example, right? So people are going back to the roots of where they initually were exploring some of these technologies. And it really isn't acoven focused a, you know, disease treatment.
Transcript
Play full episode